Cargando…

Therapeutic potential of targeting protein for Xklp2 silencing for pancreatic cancer

The targeting protein for Xklp2 (TPX2) is a microtubule- and, cell cycle-associated protein who’s overexpression has been reported in various malignancies. In this study, we verified the overexpression of TPX2 in both surgically resected specimens of pancreatic cancer and multiple pancreatic cancer...

Descripción completa

Detalles Bibliográficos
Autores principales:	Miwa, Tomohiro, Kokuryo, Toshio, Yokoyama, Yukihiro, Yamaguchi, Junpei, Nagino, Masato
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	John Wiley & Sons, Ltd 2015
Materias:	Cancer Biology
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4529347/ https://www.ncbi.nlm.nih.gov/pubmed/25914189 http://dx.doi.org/10.1002/cam4.453

Ejemplares similares

Inhibition of SNW1 association with spliceosomal proteins promotes apoptosis in breast cancer cells
por: Sato, Naoki, et al.
Publicado: (2015)

Nek2 siRNA therapy using a portal venous port–catheter system for liver metastasis in pancreatic cancer
por: Kokuryo, Toshio, et al.
Publicado: (2016)

Comprehensive Analysis of the Oncogenic Role of Targeting Protein for Xklp2 (TPX2) in Human Malignancies
por: Shao, Ting, et al.
Publicado: (2022)

Target Protein for Xklp2 Functions as Coactivator of Androgen Receptor and Promotes the Proliferation of Prostate Carcinoma Cells
por: Sun, Baisheng, et al.
Publicado: (2022)

Serine‐227 in the N‐terminal kinase domain of RSK2 is a potential therapeutic target for mantle cell lymphoma
por: Matsumura‐Kimoto, Yayoi, et al.
Publicado: (2020)

Single-Incision Laparoscopic Cholecystectomy after Endoscopic Nasogallbladder Drainage: A Case Report
por: Igami, Tsuyoshi, et al.
Publicado: (2015)

Vacuolar ATPase as a potential therapeutic target and mediator of treatment resistance in cancer
por: Whitton, Bradleigh, et al.
Publicado: (2018)

Prognostic role of targeting protein for Xklp2 in solid tumors: A PRISMA-compliant systematic review and meta-analysis
por: Wang, Shijie, et al.
Publicado: (2018)

CCL2 as a potential therapeutic target for clear cell renal cell carcinoma
por: Arakaki, Ryuichiro, et al.
Publicado: (2016)

ITGB4 as a novel serum diagnosis biomarker and potential therapeutic target for colorectal cancer
por: Jiang, Xia, et al.
Publicado: (2021)

peIF4E as an independent prognostic factor and a potential therapeutic target in diffuse infiltrating astrocytomas
por: Martínez‐Sáez, Elena, et al.
Publicado: (2016)

Protein disulphide isomerase inhibition as a potential cancer therapeutic strategy
por: Powell, Lauren E., et al.
Publicado: (2021)

Occult mucin-producing cholangiocarcinoma in situ: a rare clinical case with difficult tumour staging
por: Kiriyama, Muneyasu, et al.
Publicado: (2017)

Long-term survival after multidisciplinary therapy for residual gallbladder cancer with peritoneal dissemination: a case report
por: Kuga, Daisuke, et al.
Publicado: (2017)

Evaluation of CHK1 activation in vulvar squamous cell carcinoma and its potential as a therapeutic target in vitro
por: Wang, Zhihui, et al.
Publicado: (2018)

Maternal embryonic leucine zipper kinase: A novel biomarker and a potential therapeutic target of cervical cancer
por: Wang, Juan, et al.
Publicado: (2018)

Targeting claudin‐4 enhances chemosensitivity of pancreatic ductal carcinomas
por: Sasaki, Takamitsu, et al.
Publicado: (2019)

Challenges in validating candidate therapeutic targets in cancer
por: Settleman, Jeffrey, et al.
Publicado: (2018)

Assessing the mechanism and therapeutic potential of modulators of the human Mediator complex-associated protein kinases
por: Clarke, Paul A, et al.
Publicado: (2016)

Protein phosphatase 2 regulatory subunit B''Alpha silencing inhibits tumor cell proliferation in liver cancer
por: Chen, Huijuan, et al.
Publicado: (2019)

Molecular crosstalk between cancer cells and tumor microenvironment components suggests potential targets for new therapeutic approaches in mobile tongue cancer
por: Dayan, Dan, et al.
Publicado: (2012)

Proteomic profiling of FBXW7‐mutant serous endometrial cancer cells reveals upregulation of PADI2, a potential therapeutic target
por: Urick, Mary Ellen, et al.
Publicado: (2020)

MASTL: A novel therapeutic target for Cancer Malignancy
por: Fatima, Iram, et al.
Publicado: (2020)

MicroRNA‐124: An emerging therapeutic target in cancer
por: Jia, Xinqi, et al.
Publicado: (2019)

Protein arginine methyltransferase 5: A novel therapeutic target for triple‐negative breast cancers
por: Vinet, Mathilde, et al.
Publicado: (2019)

Photoimmunotherapy targeting biliary‐pancreatic cancer with humanized anti‐TROP2 antibody
por: Nishimura, Takashi, et al.
Publicado: (2019)

Effects of Nrf2 silencing on oxidative stress‐associated intestinal carcinogenesis in mice
por: Yokoo, Yuh, et al.
Publicado: (2016)

Application of fluorescent cholangiography during single-incision laparoscopic cholecystectomy for cholecystitis with a right-sided round ligament: Preliminary experience
por: Nojiri, Motoi, et al.
Publicado: (2018)

Left trisectionectomy combined with resection of the right hepatic vein and inferior vena cava after right hepatic vein embolization for advanced intrahepatic cholangiocarcinoma
por: Suzuki, Toshihiro, et al.
Publicado: (2019)

A case of small in situ perihilar cholangiocarcinoma incidentally accompanied by benign bile duct stricture after open cholecystectomy
por: Maeda, Takashi, et al.
Publicado: (2019)

Strong antitumor efficacy of a pancreatic tumor‐targeting oncolytic adenovirus for neuroendocrine tumors
por: Yamamoto, Yuki, et al.
Publicado: (2017)

Blockade of CD82 by a monoclonal antibody potentiates anti-leukemia effects of AraC in vivo
por: Nishioka, Chie, et al.
Publicado: (2015)

Inhibition of MMP14 potentiates the therapeutic effect of temozolomide and radiation in gliomas
por: Ulasov, Ilya, et al.
Publicado: (2013)

The role of EZH2 and DNA methylation in the silencing of the tumour suppressor RUNX3 in colorectal cancer
por: Kodach, Liudmila L., et al.
Publicado: (2010)

Novel therapeutic targets in salivary duct carcinoma uncovered by comprehensive molecular profiling
por: Gargano, Stacey M., et al.
Publicado: (2019)

Therapeutic potential of CRISPR/Cas9 gene editing in engineered T‐cell therapy
por: Gao, Qianqian, et al.
Publicado: (2019)

Cytoplasmic RASSF2A is a proapoptotic mediator whose expression is epigenetically silenced in gastric cancer
por: Maruyama, Reo, et al.
Publicado: (2008)

Epigenetic silencing of miR‐1271 enhances MEK1 and TEAD4 expression in gastric cancer
por: Lim, Byungho, et al.
Publicado: (2018)

Aberrant DNA hypermethylation reduces the expression of the desmosome-related molecule periplakin in esophageal squamous cell carcinoma
por: Otsubo, Takeshi, et al.
Publicado: (2015)

Replication Study: The CD47-signal regulatory protein alpha (SIRPa) interaction is a therapeutic target for human solid tumors
por: Horrigan, Stephen K
Publicado: (2017)

Cannot write session to /tmp/vufind_sessions/sess_os3i12jmnlmpg1asmtdfdt8fq4